Overview

A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity

Status:
Completed
Trial end date:
2019-11-04
Target enrollment:
Participant gender:
Summary
This study will look at how the emptying of the participant's stomach after a meal is affected by semaglutide (a new medicine) compared to a "dummy" medicine. In addition, the study will also look at the effect of semaglutide on the participant's appetite and energy intake. Participants will either get semaglutide or "dummy" medicine - which treatment any participant gets is decided by chance. Participants will take 1 injection per week. The study medicine is injected with a thin needle in the stomach, thigh or upper arm. The study will last for about 27 weeks (from first treatment to last check-up). Participants will have 8 visits at the clinic with the study doctor.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S